| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |